Keith Vrbicky

1.6k total citations · 1 hit paper
7 papers, 603 citations indexed

About

Keith Vrbicky is a scholar working on Infectious Diseases, Animal Science and Zoology and Immunology. According to data from OpenAlex, Keith Vrbicky has authored 7 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Animal Science and Zoology and 2 papers in Immunology. Recurrent topics in Keith Vrbicky's work include SARS-CoV-2 and COVID-19 Research (3 papers), Animal Virus Infections Studies (3 papers) and Immunotherapy and Immune Responses (2 papers). Keith Vrbicky is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Animal Virus Infections Studies (3 papers) and Immunotherapy and Immune Responses (2 papers). Keith Vrbicky collaborates with scholars based in United States. Keith Vrbicky's co-authors include Ying Chang, Jacqueline M. Miller, Bethany Girard, Rituparna Das, Darin K. Edwards, David C. Montefiori, Nichole McGhee, Andrea Sutherland, Lindsey R. Baden and Brandon Essink and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

In The Last Decade

Keith Vrbicky

7 papers receiving 587 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

2022 346 citations Spyros Chalkias, Charles Harper et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith Vrbicky United States	5	377	100	97	83	78	7	603
Dami A. Collier United Kingdom	11	217 0.6×	147 1.5×	98 1.0×	19 0.2×	5 0.1×	20	749
S HSIEH Taiwan	11	82 0.2×	203 2.0×	32 0.3×	24 0.3×	8 0.1×	16	617
Lin Gan China	15	296 0.8×	156 1.6×	6 0.1×	48 0.6×	139 1.8×	56	799
Wesam S. Ahmed Qatar	10	106 0.3×	162 1.6×	16 0.2×	16 0.2×	10 0.1×	24	361
Senthil Visaga Ambi India	9	137 0.4×	133 1.3×	8 0.1×	16 0.2×	11 0.1×	13	537
Cassandra Yun United States	11	227 0.6×	59 0.6×	8 0.1×	18 0.2×	17 0.2×	23	417
Ovidiu‐Dumitru Ilie Romania	13	93 0.2×	93 0.9×	12 0.1×	8 0.1×	38 0.5×	52	504
Mohammad‐Ali Jenabian Canada	22	386 1.0×	261 2.6×	24 0.2×	11 0.1×	6 0.1×	66	1.2k
Meghan J. Chenoweth Canada	17	73 0.2×	326 3.3×	98 1.0×	5 0.1×	17 0.2×	41	1.0k

Countries citing papers authored by Keith Vrbicky

Since Specialization

Citations

This map shows the geographic impact of Keith Vrbicky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Vrbicky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Vrbicky more than expected).

Fields of papers citing papers by Keith Vrbicky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Vrbicky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Vrbicky. The network helps show where Keith Vrbicky may publish in the future.

Co-authorship network of co-authors of Keith Vrbicky

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Vrbicky. A scholar is included among the top collaborators of Keith Vrbicky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Vrbicky. Keith Vrbicky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Chalkias, Spyros, Charles Harper, Keith Vrbicky, et al.. (2023). Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19. Nature Communications. 14(1). 5125–5125. 11 indexed citations

2.

Chu, Laurence, Keith Vrbicky, David C. Montefiori, et al.. (2022). Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial. Nature Medicine. 28(5). 1042–1049. 56 indexed citations

3.

Chalkias, Spyros, Charles Harper, Keith Vrbicky, et al.. (2022). A Bivalent Omicron-Containing Booster Vaccine against Covid-19. New England Journal of Medicine. 387(14). 1279–1291. 346 indexed citations breakdown →

4.

Bradley, Paul, Vishaal Mehra, Keith Vrbicky, et al.. (2017). Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility. Journal of Psychiatric Research. 96. 100–107. 146 indexed citations

5.

Cohen, Daniel M., et al.. (2014). 1402Multicenter Clinical Evaluation of the Novel Alere i Strep Isothermal Nucleic Acid Amplification Test. Open Forum Infectious Diseases. 1(suppl_1). S369–S369. 1 indexed citations

6.

Vrbicky, Keith, et al.. (1991). Home uterine activity monitoring in a rural setting. International Journal of Gynecology & Obstetrics. 34(3). 290–290. 4 indexed citations

7.

Vrbicky, Keith, et al.. (1982). Evidence for the involvement of β-endorphin in the human menstrual cycle. Fertility and Sterility. 38(6). 701–704. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact